5CPA Evaluation Final Reports

Describes the outcomes and options of the three most recent evaluations undertaken under the Fifth Community Pharmacy Agreement (Fifth Agreement).

Page last updated: 23 September 2015

The five year Sixth Community Pharmacy Agreement (6CPA) between the Commonwealth of Australia and the Pharmacy Guild of Australia commenced on 1 July 2015 and is a key element of the PBS Access and Sustainability Package, announced in the 2015-16 Budget. Further information about the 6CPA can be found on the PBS website.


5CPA Evaluation Final Reports

  • Through the Fifth Agreement, the Department and the Guild agreed on an overarching Evaluation Framework for the Fifth Agreement.
  • The Evaluation Framework was developed in consultation with a range of stakeholders through the Programmes Reference Group (PRG).
  • The Evaluation Framework (the Framework) for the Fifth Agreement has provided a consistent mechanism for the evaluation of individual programmes across the Fifth Agreement.
  • Under the Framework, the Department, in consultation with the Guild and with advice from the PRG, developed an Evaluation Plan that set out priorities and timeframes for Fifth Agreement evaluations.
  • The PRG had an ongoing role in Fifth Agreement programme evaluations, including:
    • the provision of advice on evaluation design and methodology;
    • acting as an Expert Reference Group (as required); and
    • the provision of advice on interim and final evaluation reports and findings.
  • All evaluations are now complete, with three evaluations finalised in 2015:
    • Combined Review of the Fifth Community Pharmacy Agreement Medication Management programmes - commenced on 23 July 2013 and was completed on 15 January 2015 (PricewaterhouseCoopers);
    • Review of the Governance Structures established under the Fifth Community Pharmacy Agreement - commenced on 28 August 2014 and was completed on 29 January 2015 (Siggins Miller Consultants Pty Ltd); and
    • Combined Thematic Review of Access, Consumer Experience and Quality Use of Medicines under the Fifth Community Pharmacy Agreement - commenced on 21 August 2014 and was completed on 13 March 2015 (KPMG).
  • The evaluations aim to provide information to ensure future programmes and services are appropriately targeted.
  • The key findings and options provided in the evaluation draft Final Reports have been utilised by the Department to inform consultation, planning and the subsequent negotiation of the Sixth Community Pharmacy Agreement (Sixth Agreement).
Information and Key Findings of the three most recent Evaluations

Combined Review of 5CPA Medication Management Programmes

  • The Final Report for the Combined Review of 5CPA Medication Management Programmes (the Combined Review) was provided on 15 January 2015.
  • The Combined Review covered the HMR, RMMR, Medscheck, Diabetes Medscheck, Clinical Interventions, Dose Administration Aids and Staged Supply programmes.
  • PricewaterhouseCoopers (PwC) was the preferred provider selected to undertake the Combined Review.
  • Several Stakeholder consultations and focus group sessions were completed.
  • In addition, a Practitioner survey and a Consumer survey, developed in consultation with the Department and the PRG, were undertaken.
  • The Combined Review findings provide a number of options for consideration in determining future arrangements for medication management programmes:
    • Design and trial of service models specific to pharmacy with appropriate reimbursement models - based on a ‘needs-based’ framework, integrating triage and assessment of clinical need.
    • Trialling incentivised models for professional collaborationdesigning a model based on patient outcomes, with a focus on quality of services delivered.
    • Reliable cost-benefit analysis is criticalimplement a more sophisticated approach towards data collection.
    • Increasing education and awareness of programmes and services - for both consumers and other health professionals.
    • Applying flexibility in administration processes - applying some flexibility in the administration of the programmes and services to allow for cultural differences/rurality in certain target groups could improve access and reach.
    • Establishing appropriate monitoring and auditing processes - implement a more sophisticated approach towards collection of data, combined with regular reporting to enable consumer health outcomes to be more effectively monitored and measured over time.

Review of Governance Structures established under the 5CPA

  • The Final Report for the Review of Governance Structures established under the Fifth Agreement (the Governance Review) was provided on 29 January 2015. 
  • The Governance Review reports on and assesses the efficacy of the governance structures established for the Fifth Agreement, including the Agreement Consultative Committee and the PRG committee structures, programme administrative arrangements and how stakeholders contribute to programme development and management.
  • The key themes of Efficiency, Effectiveness, Transparency and Accountability were considered.
  • Siggins Miller Consultants Pty Ltd was the preferred provider selected to undertake the evaluation.
  • Stakeholder consultations and surveys, combined with a document review, were undertaken to gather information and data for assessment.
  • The Review has provided a number of options to support appropriate consultation and Governance arrangements for the Sixth Agreement.

Combined Thematic Review of Access, Consumer Experience and Quality Use of Medicines under the 5CPA

  • The Final report for the Combined Thematic Review of Access, Consumer Experience and Quality Use of Medicines under the Fifth Agreement (the Thematic Review) was provided on 13 March 2015.
  • The Thematic Review reports on how Fifth Agreement programmes and services contribute to improving consumer health outcomes through Access, Consumer Experience and Quality Use of Medicines.
  • KPMG Australia Pty Ltd was the preferred provider selected to undertake the Combined Thematic Review.
  • KPMG provided a presentation to the PRG on 8 October 2014 and further consulted with members to solicit their expert opinions and advice on the scope and further development of a detailed stakeholder consultation survey.
  • Based on the Thematic Review key findings, the Review identified five areas for consideration in determining programme and service arrangements for the Sixth Community Pharmacy Agreement that will seek to improve consumer health outcomes:
  1. A needs based, medication management continuum for consumers;
  2. Consistent QUM indicators for evaluating programmes;
  3. Continued and consistent measurement of the consumer experience;
  4. Integration of 5CPA Aboriginal and Torres Strait Islander programmes with related programmes outside of 5CPA; and
  5. Overarching evaluation through the life of the community pharmacy agreement.